Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Design|June 22, 2012
Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical reviewDerik Hermann, Miriam SchneiderEuropean Archives of Psychiatry and Clinical Neuroscience|October 19, 2010
Individualised treatment in alcohol-dependent patientsKarl Mann, Derik HermannJournal of Psychiatry & Neuroscience : JPN|January 13, 2005
Testing the association between thyroid dysfunction and psychiatric diagnostic group in an iodine-deficient areaDerik Hermann, Walter Hewer, Florian LederbogenAddiction (Abingdon, England)|November 2, 2002
Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholismDerik Hermann, Andreas Heinz, Karl MannForensic Science International|November 14, 2006
Deposition of cannabinoids in hair after long-term use of cannabisGisela Skopp, Peter Strohbeck-Kuehner, Karl Mann, et al.Psychiatrische Praxis|June 13, 2012
[Pregabalin for the reduction of opiate withdrawal symptoms]Nina Kämmerer, Tagrid Lemenager, Martin Grosshans, et al.Addiction (Abingdon, England)|May 6, 2009
Reduced affective symptoms during tobacco dependence treatment with vareniclineMartin Grosshans, Jochen Mutschler, Derik Hermann, et al.International Journal of Legal Medicine|February 9, 2011
Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosageGisela Skopp, Anja Kniest, Joerg Haisser, et al.Addiction Biology|September 30, 2005
Low efficacy of non-opioid drugs in opioid withdrawal symptomsDerik Hermann, Eckard Klages, Helga Welzel, et al.Deutsches Arzteblatt International|August 26, 2010
Dextromethorphan withdrawal and dependence syndromeJochen Mutschler, Anne Koopmann, Martin Grosshans, et al.Pageof 8